Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'


According to a market report by Lucintel, the future of the cell dissociation market looks promising with opportunities in pharmaceutical and biotechnology companies and research and academics. The global cell dissociation market is expected to reach an estimated $0.7 billion by 2028 with a CAGR of 14.4% from 2023 to 2028. The major drivers for this market are increasing cell-based research and development initiatives by biopharmaceutical companies and growing demand for personalized medicine.



In this market, tissue dissociation and cell detachment are the major type segments. Lucintel forecasts that tissue dissociation are expected to remain the largest type segment over the forecast period due to rising government funding for chronic disease research and increase in the R&D expenditure by the pharmaceutical companies for the development of antibodies and personalised treatments.



Within this market, pharmaceutical and biotechnology companies are expected to remain the largest end user segment over the forecast period due to increasing usage of cell dissociation enzymes in the pharmaceutical and biotechnology sectors.



North America is expected to remain the largest region over the forecast period due to increasing incidences of chronic diseases, growing investment by governments in R&D activities, and the dominant presence of major market players in this region.

Merck KGaA, Danaher Corporation , Thermo Fisher Scientific ,Corning Incorporated, and Becton are the major suppliers in the global cell dissociation market.  



Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global cell dissociation market by product, tissue type, application, end use industry, and region. Lucintel has compiled a comprehensive research report titled “Growth Opportunities in the Global Cell Dissociation Market 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global cell dissociation market by product, tissue type, application, end use industry, and region, as follows:


Cell Dissociation Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:




  • Enzymatic Dissociation Products


    • Collagenase


    • Trypsin


    • Papain


    • Elastase


    • DNase


    • Hyaluronidase


    • Other Enzymes




  • Non-Enzymatic Dissociation Agents


  • Instruments & Accessories



Cell Dissociation Market by Tissue Type [Value ($B) Shipment Analysis from 2017 to 2028]:




  • Connective Tissues


  • Epithelial Tissues


  • Other Tissues



Cell Dissociation Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:




  • Tissue Dissociation


  • Cell Detachment



Cell Dissociation Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:




  • Pharmaceutical and Biotechnology Companies


  • Research and Academics


  • Other



Cell Dissociation Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:




  • North America


  • Europe


  • Asia Pacific


  • The Rest of the World



This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or email us at helpdesk@lucintel.com.

 


About Lucintel



Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

 


This report answers the following 11 key questions:



Q.1. What are some of the most promising, high-growth opportunities for the global cell dissociation market by product (enzymatic dissociation products, (collagenase, trypsin, papain, elastase, dnase, hyaluronidase, and other enzymes), non-enzymatic dissociation agents, and instruments & accessories), tissue type (connective tissues, epithelial tissues, and other tissues), application (tissue dissociation and cell detachment), end use industry (pharmaceutical and biotechnology companies, research and academics, and other end users), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or type substitution?

Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?